European Union announces new programme to improve Parkinson’s diagnosis

News

Author: Parkinson's Life editorsPublished: 17 January 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

PD-Podcast-DBS

The European Union has announced the launch of the Magnetic Diagnostic Assay for Neurodegenerative Diseases (MADIA) – a project with the ultimate goal of improving diagnosis for those living with Parkinson’s and Alzheimer’s.

The project, which is in partnership with a range of international universities and institutions, will focus on the development of a novel device that will help clinicians perform a simple click and analysis to diagnose both conditions.

Dr Francisco Campos, of the Clinical Neurosciences Research Laboratory, said: “An early diagnosis is crucial to maximise the effectiveness of the treatments in order to mitigate the devastating effects of these illnesses and slow disease progression.

“MADIA is funded by the European Union’s Horizon 2020 research and innovation programme, and consists of a multitasking team with more than 50 professionals in the fields of biology, physics and engineering.”

For comprehensive information about Parkinson’s diagnosis please visit the EPDA website.

Go Back

Share this story

Comments


Related articles


Meal Soup lead

Recipes & Nutrition

In the kitchen with Yves: why meal soups are good for you

Turning soup into a filling dish that is easy to chew and swallow

READ MORE
May May Ali

Interviews

May May Ali: “My father was misdiagnosed for years”

Muhammad Ali's daughter speaks out ahead of US Unity Walk

READ MORE
Crowded sidewalk on Oxford Street in London

Special reports

Parkinson’s prevalence expected to increase by 18% in next seven years

Aging UK population could see increase in Parkinson’s over time

READ MORE